Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Novel partial 5HT3 agonist pumosetrag reduces acid reflux events in uninvestigated GERD patients after a standard refluxogenic meal: a randomized, double-blind, placebo-controlled pharmacodynamic study. [electronic resource] by
- Choung, R S
- Locke, G R
- Francis, D D
- Katzka, D
- Winkle, P J
- Orr, W C
- Crowell, M D
- Devault, K
- Harmsen, W S
- Zinsmeister, A R
- Talley, N J
Producer: 20140818
In:
Neurogastroenterology and motility vol. 26
Availability: No items available.
|